Abstract
Latinos in the US experience a 60% higher death rate from primary hepatocellular carcinoma (HCC) when compared to Non-Latinos. The goal of this study was to examine risk factors that are associated with ethnic disparities among HCC patients seen at the transplant center of a metropolitan medical center in New York City. We compared HCC risk factors in 140 Non-Latino and 55 Latino patients that presented with HCC from 1995 to 2003. Surnames were used to define Latino and Non-Latino HCC patients in a retrospective analysis. Latino and Non-Latino HCC patients did not vary by gender or age at presentation (mean Latino age 60.8). Latino HCC patients had a higher frequency of presentation with advanced disease, defined as patients with unresectable HCC, than non Latino HCC patients (Latino 52.7%; 95% CI 39.1–66.3 vs. Non-Latino vs. 36.4%; 95% CI 28.3–44.4). Latinos were more likely than Non Latinos to have underlying HCV (34.5 vs. 22.1%, P < .0001; adjusted odds ratio [Siegel, 2008 #564], 3.69; 95% CI, 1.16–11.7) and cryptogenic liver diseases (7.2 vs. 3.5%, P < .0001; OR 8.86; 95% CI, 1.21–65.0) after adjusting for age, gender and alfa-fetoprotein levels. Although more advanced disease may signal delay in access to care or more aggressive disease, HCV infection and cryptogenic cirrhosis at presentation are likely key factors for the greater burden of HCC among Latinos in New York City.
Similar content being viewed by others
References
Parkin, D. M. (2004). International variation. Oncogene, 23(38), 6329–6340.
Benowitz, S. (2007). Liver cancer biomarkers struggling to succeed. Journal of the National Cancer Institute, 99(8), 590–591.
El-Serag, H. B. (2004). Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology, 127(5 Suppl 1), S27–S34.
Kim, W. R., Gores, G. J., Benson, J. T., Therneau, T. M., & Melton, L. J., I. I. I. (2005). Mortality and hospital utilization for hepatocellular carcinoma in the United States. Gastroenterology, 129(2), 486–493.
El-Serag, H. B. (2007). Translational research: The study of community effectiveness in digestive and liver disorders. Gastroenterology, 132(1), 8–10.
El-Serag, H. B., Marrero, J. A., Rudolph, L., & Reddy, K. R. (2008). Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology, 134(6), 1752–1763.
Siegel, A. B., McBride, R., El-Serag, H. B., Hershman, D. L., Brown, R., Renz, J., et al. (2006). Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States. Paper presented at the Gastrointestinal Cancers Symposium.
Bosch, F. X., Ribes, J., Diaz, M., & Cleries, R. (2004). Primary liver cancer: Worldwide incidence and trends. Gastroenterology, 127(5 Suppl 1), S5–S16.
Caldwell, S. H., Chang, C. Y., Nakamoto, R. K., & Krugner-Higby, L. (2004). Mitochondria in nonalcoholic fatty liver disease. Clinics in Liver Disease, 8(3), 595–617.
Lagiou, P., Kuper, H., Stuver, S. O., Tzonou, A., Trichopoulos, D., & Adami, H. O. (2000). Role of diabetes mellitus in the etiology of hepatocellular carcinoma. Journal of the National Cancer Institute, 92(13), 1096–1099.
Caldwell, S. H., Crespo, D. M., Kang, H. S., & Al-Osaimi, A. M. (2004). Obesity and hepatocellular carcinoma. Gastroenterology, 127(5 Suppl 1), S97–S103.
Mendez-Sanchez, N., Zamora-Valdes, D., Vasquez-Fernandez, F., & Uribe, M. (2007). Hepatocellular carcinoma in hispanics. Annals of Hepatology, 6(4), 279–280.
ACS. (2005). Facts and figures for hispanics/latinos in the United Sates 2003–2005.
El-Serag, H. B., Lau, M., Eschbach, K., Davila, J., & Goodwin, J. (2007). Epidemiology of hepatocellular carcinoma in hispanics in the United States. Archives of Internal Medicine, 167(18), 1983–1989.
Grem, J. L., Morrison, G., Guo, X. D., Agnew, E., Takimoto, C. H., Thomas, R., et al. (2005). Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors. Journal of Clinical Oncology, 23(9), 1885–1893.
NCI. (2006). State cancer profiles. National Cancer Institute.
NYSCR. (2006). Cancer incidence and mortality by region, 1999–2003. New York City.
Davila, J. A., & El-Serag, H. B. (2006). Racial differences in survival of hepatocellular carcinoma in the United States: A population-based study. Clinical Gastroenterology and Hepatology, 4(1), 104–110. quiz 104–105.
Siegel, A. B., McBride, R., El-Serag, H. B., Hershman, D. L., Brown, R., Renz, J., et al. (2006). Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States. Paper presented at the Gastrointestinal Cancers Symposium.
Perez-Stable, E. J., Hiatt, R. A., Sabogal, F., & Otero-Sabogal, R. (1995). Use of Spanish surnames to identify Latinos: Comparison to self-identification. Journal of the National Cancer Institute (18), 11–15.
Lelutiu-Weinberger, C., Pouget, E. R., Des Jarlais, D. D., Cooper, H. L., Scheinmann, R., Stern, R., et al. (2009). A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups. Social Science and Medicine, 68(3), 579–590.
Fiscella, K., & Fremont, A. M. (2006). Use of geocoding and surname analysis to estimate race and ethnicity. Health Services Research, 41(4 Pt 1), 1482–1500.
Elliott, M. N., Fremont, A., Morrison, P. A., Pantoja, P., & Lurie, N. (2008). A new method for estimating race/ethnicity and associated disparities where administrative records lack self-reported race/ethnicity. Health Services Research, 43(5), 1722–1736.
Krieger, N., Chen, J. T., Waterman, P. D., Rehkopf, D. H., & Subramanian, S. V. (2005). Painting a truer picture of US socioeconomic and racial/ethnic health inequalities: The public health disparities geocoding project. American Journal of Public Health, 95(2), 312–323.
Fremont, A. M., Bierman, A., Wickstrom, S. L., Bird, C. E., Shah, M., Escarce, J. J., et al. (2005). Use of geocoding in managed care settings to identify quality disparities. Health Affairs (Millwood), 24(2), 516–526.
Word, D. L., & Colby, P. J. (1996). Building a Spanish surname list for the 1990’s—A new approach to an old problem. USA: Population Division, US Bureau of the Census.
Perkins, R. C. (1993). Evaluating the Passel-Word Spanish surname list: 1990 Decennial census post enumeration survey results. USA: Population Division, US Bureau of the Census.
Nash, G. M., Saltz, L. B., Kemeny, N. E., Minsky, B., Sharma, S., Schwartz, G. K., et al. (2002). Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Annals of Surgical Oncology, 9(10), 954–960.
Ghai, S., Dill-Macky, M., Wilson, S., & Haider, M. (2005). Fluid–fluid levels in cavernous hemangiomas of the liver: Baffled? AJR American Journal of Roentgenology, 184(3 Suppl), S82–S85.
Crum, N. F., et al. (2006). Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. Journal of Acquired Immune Deficiency Syndromes, 41(2), 194–200.
Bosch, F. X., Ribes, J., Cleries, R., & Diaz, M. (2005). Epidemiology of hepatocellular carcinoma. Clinics in Liver Disease, 9(2), 191–211.
Di Bisceglie, A. M., Lyra, A. C., Schwartz, M., Reddy, R. K., Martin, P., Gores, G., et al. (2003). Hepatitis C-related hepatocellular carcinoma in the United States: Influence of ethnic status. American Journal of Gastroenterology, 98(9), 2060–2063.
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., et al. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine, 341(8), 556–562.
Fraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., et al. (2005). Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nature Genetics, 37(4), 391–400.
Hepburn, M. J., & Lawitz, E. J. (2004). Seroprevalence of hepatitis C and associated risk factors among an urban population in Haiti. BMC Gastroenterology, 4(1), 31.
Smikle, M. F., Dowe, G., Williams, E. M., & Thesiger, C. (2000). Antibodies to hepatitis B virus and hepatitis C virus in residential detoxification clients in Jamaica. Human Antibodies, 9(4), 231–233.
Hossain, P., Kawar, B., & El Nahas, M. (2007). Obesity and diabetes in the developing world—A growing challenge. New England Journal of Medicine, 356(3), 213–215.
Duseja, A., Nanda, M., Das, A., Das, R., Bhansali, A., & Chawla, Y. (2004). Prevalence of obesity, diabetes mellitus and hyperlipidaemia in patients with cryptogenic liver cirrhosis. Tropical Gastroenterology, 25(1), 15–17.
Bugianesi, E. (2007). Non-alcoholic steatohepatitis and cancer. Clinics in Liver Disease, 11(1), 191–207.
Svegliati-Baroni, G., Bugianesi, E., Bousheral, T., Ridolfi, F., Marini, F., Tarsetti, F., et al. (2007). Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in nonalcoholic fatty liver disease. Gut, 56(9), 1296–1301.
N’Kontchou, G., Paries, J., Htar, M. T., Ganne-Carrie, N., Costentin, L., Grando-Lemaire, V., et al. (2006). Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis. Clinical Gastroenterology and Hepatology, 4(8), 1062–1068.
Gomez, M., Ramirez, M., & Disdier, O. (2006). Prevalence of the metabolic syndrome among a determined Puerto Rican population. Puerto Rico Health Sciences Journal, 25(2), 111–116.
Meigs, J. B., Wilson, P. W., Nathan, D. M., D’Agostino, R. B., Sr., Williams, K., & Haffner, S. M. (2003). Prevalence and characteristics of the metabolic syndrome in the San Antonio heart and Framingham offspring studies. Diabetes, 52(8), 2160–2167.
Haan, M. N., Mungas, D. M., Gonzalez, H. M., Ortiz, T. A., Acharya, A., & Jagust, W. J. (2003). Prevalence of dementia in older latinos: The influence of type 2 diabetes mellitus, stroke and genetic factors. Journal of the American Geriatrics Society, 51(2), 169–177.
Acknowledgments
This research was supported in part by funds from the federal government, NCI grant number 5T32CA009529-20, NIA grant number 2P30AG-15294; and NCMHD grant number 5S21MD008130-02.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guerrero-Preston, R., Siegel, A., Renz, J. et al. HCV Infection and Cryptogenic Cirrhosis are Risk Factors for Hepatocellular Carcinoma Among Latinos in New York City. J Community Health 34, 500–505 (2009). https://doi.org/10.1007/s10900-009-9184-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10900-009-9184-2